Literature DB >> 8782636

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

C D Gardner1, S P Fortmann, R M Krauss.   

Abstract

OBJECTIVE: To investigate the prospective association of low-density lipoprotein (LDL) particle diameter with the incidence of fatal and nonfatal coronary artery disease (CAD).
DESIGN: A nested case-control study.
SETTING: Cases and controls were identified from a population-based sample of men and women combining all of the 5 cross-sectional surveys conducted from 1979 to 1990 of the Stanford Five-City Project (FCP). PARTICIPANTS: Incident CAD cases were identified through FCP surveillance between 1979 and 1992. Controls were matched by sex, 5-year age groups, survey time point, ethnicity, and FCP treatment condition. The sample included 124 matched pairs: 90 pairs of men and 34 pairs of women. MAIN OUTCOME MEASURES: LDL peak particle diameter (LDL size) was determined by gradient gel electrophoresis on plasma samples collected during the cross-sectional surveys (stored at 70 degrees C for 5-15 years). Established CAD risk-factor data were available from FCP baseline measurements.
RESULTS: LDL size was smaller among CAD cases than controls (mean +/- SD) (26.17 +/- 1.00 nm vs 26.68 +/- 0.90 nm; P<.001). The association was graded across control quintiles of LDL size. The significant case-control difference in LDL size was independent of levels of high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (non-HDL-C), triglyceride, smoking, systolic blood pressure, and body mass index, but was not significant after adjusting for the ratio of total cholesterol (TC) to HDL-C (TC:HDL-C). Among all the physiological risk factors, LDL size was the best differentiator of CAD status in conditional logistic regression. However, when added to the physiological parameters above, the TC:HDL-C ratio was found to be a stronger independent predictor of CAD status.
CONCLUSION: LDL size was significantly smaller in CAD cases than in controls in a prospective, population-based study. These findings support other evidence of a role for small, dense LDL particles in the etiology of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782636

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  137 in total

1.  Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial.

Authors:  A D Sniderman; J Bergeron; J Frohlich
Journal:  CMAJ       Date:  2001-01-09       Impact factor: 8.262

Review 2.  The effect of n-3 fatty acids on low density lipoprotein subfractions.

Authors:  B A Griffin
Journal:  Lipids       Date:  2001       Impact factor: 1.880

Review 3.  Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease.

Authors:  H N Ginsberg
Journal:  Curr Cardiol Rep       Date:  1999-09       Impact factor: 2.931

Review 4.  Small, dense low-density lipoprotein: risk or myth?

Authors:  Ngoc-Anh Le
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

Review 5.  Low-density lipoprotein particle number and risk for cardiovascular disease.

Authors:  William C Cromwell; James D Otvos
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

6.  A genomewide search using an original pairwise sampling approach for large genealogies identifies a new locus for total and low-density lipoprotein cholesterol in two genetically differentiated isolates of Sardinia.

Authors:  Mario Falchi; Paola Forabosco; Evelina Mocci; Cesare Cappio Borlino; Andrea Picciau; Emanuela Virdis; Ivana Persico; Debora Parracciani; Andrea Angius; Mario Pirastu
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

7.  Lipoproteins: When size really matters.

Authors:  J Bruce German; Jennifer T Smilowitz; Angela M Zivkovic
Journal:  Curr Opin Colloid Interface Sci       Date:  2006-06       Impact factor: 6.448

8.  Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women.

Authors:  Jeffrey S Berger; Aileen P McGinn; Barbara V Howard; Lewis Kuller; Joann E Manson; Jim Otvos; J David Curb; Charles B Eaton; Robert C Kaplan; John K Lynch; Daniel M Rosenbaum; Sylvia Wassertheil-Smoller
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

9.  Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials.

Authors:  Tian Hu; Katherine T Mills; Lu Yao; Kathryn Demanelis; Mohamed Eloustaz; William S Yancy; Tanika N Kelly; Jiang He; Lydia A Bazzano
Journal:  Am J Epidemiol       Date:  2012-10-01       Impact factor: 4.897

Review 10.  The role of non-LDL:non-HDL particles in atherosclerosis.

Authors:  Jere P Segrest
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.